Synopsys rated Buy with $519 target, boosted by Ansys deal and China risk now priced in

Synopsys (SNPS) is rated a Buy with a 12-month price target of $519.12, reflecting that risks from China-related revenue disruptions are fully accounted for in current guidance, limiting downside and offering upside if conditions improve. The recent acquisition of Ansys significantly expands Synopsys's total addressable market by 1.5 times and accelerates integration of advanced multiphysics simulation, enhancing cross-selling opportunities and competitive positioning. Additional factors supporting the positive outlook include margin expansion, strong free cash flow guidance, AI-driven productivity gains, and strategic investments from Nvidia and Elliott. These elements combine to create a favorable risk/reward profile for investors.